Biotechnology

Drug Development Therapeutics Pharmaceuticals Drug Discovery Vaccine Development Vaccines Clinical Trials Gene Therapy Longevity Organ Transplants

Atara Biotherapeutics Hit With Investor Class Action Over FDA Setbacks

Shareholders seek recovery after alleged misstatements about tabelecleucel’s approval path.

Autoscience Raises $14 Million to Scale Automated AI Research Lab for Enterprise Deployments

Illinois Lands $1.5 Billion CSL Plasma-Therapy Plant in Kankakee County

Evo 2, an Open DNA Foundation Model, Debuts in Nature

Karnataka Bioeconomy Hits $39.2 Billion in 2025, New Report Shows

ARK Invest Rotates Into Biotech, Cuts Software Stakes in Latest Daily Trades

CSL CEO Paul McKenzie Exits Immediately as Board Installs Veteran Gordon Naylor as Interim Chief

Genentech Licenses SanegeneBio RNAi Program in Deal Worth Up to $1.7 Billion

Nuclera Extends Series C to $87 Million to Accelerate Full-Format Antibody Workflows

Jitendra Singh Lays SAMARTH Foundation, Inaugurates iDeaNA at CDFD Hyderabad

26 New Bacterial Species Found in NASA Cleanrooms Raise Planetary-Protection Questions

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Final NDAA Sends Biosecure Act to Trump’s Desk

Prolynx Raises $70 Million to Advance Ultra-Long-Acting Obesity Drugs

PsiThera Raises $47.5 Million and Appoints Eric Shaff as CEO to Push Oral TNF Small-Molecule Drugs

NeurIPS 2025 Ends With Record Attendance, Deep Split on Interpretability, and a Surge in AI for Biology

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

Khattar Pitches Ethical AI, Deep-Tech Push at IISF, Cites ₹1 Lakh Crore RDI Fund

India Outlines Rs 1 Lakh Crore RDI Fund Rollout and Seeks Industry Input

Lilly and Breakthrough to Open Gateway Labs Biotech Incubator at 2300 Market in Philadelphia